Making a Difference, Here & Beyond
The community invests in Dell Med. In return, it’s our responsibility — one we take seriously — to be agents for change and to show real impact.
More Information
Creating a New Kind of Doctor
We recruit and train physician leaders as comfortable taking on systemic challenges in health as caring for individual patients.
Improving Care. Improving Health.
We’re here to make health — including health care — better. The end goal is a complete revolution in how people get and stay healthy.
Discovery to Impact — Faster
We reward creative thinking and encourage rapid experimentation, using collaborative programs to speed promising research to market.
More Information
Let’s Do Big Things Together
True health demands that the whole work in harmony, which is why we’re dedicated to partnership. Indeed, we can’t achieve our goals without it.
More Information
Meet Dell Med
We’re rethinking the role of academic medicine in improving health — and doing so with a unique focus on our community.
More Information
Make an Appointment Directory Give Faculty Students

Mark McClellan, M.D., Ph.D.


Mark McClellan is the senior health policy advisor and professor of internal medicine at Dell Medical School. He is also the director of the Duke-Margolis Center for Health Policy at Duke University. He is a former administrator of the Centers for Medicare and Medicaid Services and former commissioner of the U.S. Food and Drug Administration (FDA), where he developed and implemented major reforms in health policy. These include the Medicare prescription drug benefit, Medicare and Medicaid payment reforms, the FDA’s Critical Path Initiative and public-private initiatives to develop better information on the quality and cost of care. He has also previously served as a member of the President’s Council of Economic Advisers and senior director for health care policy at the White House and as deputy assistant secretary for economic policy at the Department of the Treasury.

McClellan is the founding chair and a current board member of the Reagan-Udall Foundation for the FDA and is a member of the National Academy of Medicine (NAM). At NAM, he chairs the Leadership Council for Value and Science-Driven Health Care, co-chairs the guiding committee of the Health Care Payment Learning and Action Network and is a research associate at the National Bureau of Economic Research. He is also an independent director on the board of Johnson and Johnson and on the board of Alignment Health Care. He serves on a number of non-profit boards including the National Council on Aging, the National Alliance for Hispanic Health and the Long-term Quality Alliance.

He was previously an associate professor of economics and medicine with tenure at Stanford University and has twice received the Kenneth Arrow Award for Outstanding Research in Health Economics.